Clinical Trial

Study to ONO-4538 in Patients With Rhabdoid Tumor

Name: Study to ONO-4538 in Patients With Rhabdoid Tumor — clinical trial record (NCT06622941)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors

Protocol Amendment History 2 changes

notable Trial sites expanded: 5 -> 14 locations 2026-08-05

notable Sponsor changed: Ono Pharmaceutical Co. Ltd -> Ono Pharmaceutical Co., Ltd. 2026-04-19

Trial Details

NCT Number	NCT06622941
Lead Sponsor	Ono Pharmaceutical Co., Ltd.
Conditions	Rhabdoid Tumor
Enrollment	23 participants
Start Date	2024-11-25
Primary Completion	2029-01-31 (estimated)
Study Completion	2030-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-04